Sentinel lymph node biopsy in thin melanoma patients.

Dan D. Hershko, Bruce Robb, Andrew M. Lowy, Syed A. Ahmad, G. H. Ramadas, Debbie A. Soldano, Jeffrey J. Sussman

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

BACKGROUND: We sought to determine the incidence of positive sentinel lymph nodes in thin melanoma (or= III and thicker lesions (mean 0.77 mm vs. 0.47 mm), but were not different in regards to age, sex, or lesion location. Eight percent and 58% of sentinel nodes were positive by routine histology and RT-PCR, respectively. Among mapped patients, younger age was the only significant prognostic factor for node positivity. With a median follow-up of 18 months among all patients, one regional recurrence (at 2 years) has been identified. CONCLUSIONS: Given the low morbidity of sentinel lymph node biopsy, this procedure should be discussed with selected thin melanoma patients to detect microscopic disease, however PCR positivity by our methods is too commonly seen to be clinically significant in thin melanoma patients and requires additional study. (c) 2006 Wiley-Liss, Inc.

Original languageEnglish (US)
Pages (from-to)279-285
Number of pages7
JournalJournal of Surgical Oncology
Volume93
Issue number4
DOIs
StatePublished - Mar 15 2006
Externally publishedYes

Fingerprint

Sentinel Lymph Node Biopsy
Melanoma
Polymerase Chain Reaction
Histology
Morbidity
Recurrence
Incidence

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Hershko, D. D., Robb, B., Lowy, A. M., Ahmad, S. A., Ramadas, G. H., Soldano, D. A., & Sussman, J. J. (2006). Sentinel lymph node biopsy in thin melanoma patients. Journal of Surgical Oncology, 93(4), 279-285. https://doi.org/10.1002/jso.20415

Sentinel lymph node biopsy in thin melanoma patients. / Hershko, Dan D.; Robb, Bruce; Lowy, Andrew M.; Ahmad, Syed A.; Ramadas, G. H.; Soldano, Debbie A.; Sussman, Jeffrey J.

In: Journal of Surgical Oncology, Vol. 93, No. 4, 15.03.2006, p. 279-285.

Research output: Contribution to journalArticle

Hershko, DD, Robb, B, Lowy, AM, Ahmad, SA, Ramadas, GH, Soldano, DA & Sussman, JJ 2006, 'Sentinel lymph node biopsy in thin melanoma patients.', Journal of Surgical Oncology, vol. 93, no. 4, pp. 279-285. https://doi.org/10.1002/jso.20415
Hershko DD, Robb B, Lowy AM, Ahmad SA, Ramadas GH, Soldano DA et al. Sentinel lymph node biopsy in thin melanoma patients. Journal of Surgical Oncology. 2006 Mar 15;93(4):279-285. https://doi.org/10.1002/jso.20415
Hershko, Dan D. ; Robb, Bruce ; Lowy, Andrew M. ; Ahmad, Syed A. ; Ramadas, G. H. ; Soldano, Debbie A. ; Sussman, Jeffrey J. / Sentinel lymph node biopsy in thin melanoma patients. In: Journal of Surgical Oncology. 2006 ; Vol. 93, No. 4. pp. 279-285.
@article{5d65d079d9fb4511a76076eb90818028,
title = "Sentinel lymph node biopsy in thin melanoma patients.",
abstract = "BACKGROUND: We sought to determine the incidence of positive sentinel lymph nodes in thin melanoma (or= III and thicker lesions (mean 0.77 mm vs. 0.47 mm), but were not different in regards to age, sex, or lesion location. Eight percent and 58{\%} of sentinel nodes were positive by routine histology and RT-PCR, respectively. Among mapped patients, younger age was the only significant prognostic factor for node positivity. With a median follow-up of 18 months among all patients, one regional recurrence (at 2 years) has been identified. CONCLUSIONS: Given the low morbidity of sentinel lymph node biopsy, this procedure should be discussed with selected thin melanoma patients to detect microscopic disease, however PCR positivity by our methods is too commonly seen to be clinically significant in thin melanoma patients and requires additional study. (c) 2006 Wiley-Liss, Inc.",
author = "Hershko, {Dan D.} and Bruce Robb and Lowy, {Andrew M.} and Ahmad, {Syed A.} and Ramadas, {G. H.} and Soldano, {Debbie A.} and Sussman, {Jeffrey J.}",
year = "2006",
month = "3",
day = "15",
doi = "10.1002/jso.20415",
language = "English (US)",
volume = "93",
pages = "279--285",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Sentinel lymph node biopsy in thin melanoma patients.

AU - Hershko, Dan D.

AU - Robb, Bruce

AU - Lowy, Andrew M.

AU - Ahmad, Syed A.

AU - Ramadas, G. H.

AU - Soldano, Debbie A.

AU - Sussman, Jeffrey J.

PY - 2006/3/15

Y1 - 2006/3/15

N2 - BACKGROUND: We sought to determine the incidence of positive sentinel lymph nodes in thin melanoma (or= III and thicker lesions (mean 0.77 mm vs. 0.47 mm), but were not different in regards to age, sex, or lesion location. Eight percent and 58% of sentinel nodes were positive by routine histology and RT-PCR, respectively. Among mapped patients, younger age was the only significant prognostic factor for node positivity. With a median follow-up of 18 months among all patients, one regional recurrence (at 2 years) has been identified. CONCLUSIONS: Given the low morbidity of sentinel lymph node biopsy, this procedure should be discussed with selected thin melanoma patients to detect microscopic disease, however PCR positivity by our methods is too commonly seen to be clinically significant in thin melanoma patients and requires additional study. (c) 2006 Wiley-Liss, Inc.

AB - BACKGROUND: We sought to determine the incidence of positive sentinel lymph nodes in thin melanoma (or= III and thicker lesions (mean 0.77 mm vs. 0.47 mm), but were not different in regards to age, sex, or lesion location. Eight percent and 58% of sentinel nodes were positive by routine histology and RT-PCR, respectively. Among mapped patients, younger age was the only significant prognostic factor for node positivity. With a median follow-up of 18 months among all patients, one regional recurrence (at 2 years) has been identified. CONCLUSIONS: Given the low morbidity of sentinel lymph node biopsy, this procedure should be discussed with selected thin melanoma patients to detect microscopic disease, however PCR positivity by our methods is too commonly seen to be clinically significant in thin melanoma patients and requires additional study. (c) 2006 Wiley-Liss, Inc.

UR - http://www.scopus.com/inward/record.url?scp=33645057228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645057228&partnerID=8YFLogxK

U2 - 10.1002/jso.20415

DO - 10.1002/jso.20415

M3 - Article

VL - 93

SP - 279

EP - 285

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 4

ER -